Use of selective serotonin inhibitors and risk of hip/femur fractures: A population-based case-control study

被引:0
|
作者
Thio, Brahm [1 ]
de Vries, Frank [1 ]
Egberts, Antoine C. G. [1 ]
Leufkens, Bert G. M. [1 ]
van Staa, Tjeerd P. [1 ]
机构
[1] Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
484
引用
收藏
页码:S225 / S226
页数:2
相关论文
共 50 条
  • [1] Use of selective serotonin reuptake inhibitors and risk of hip/femur fractures: A population-based case-control study
    Thio, B. M. K. S.
    de Vries, F.
    Egberts, T. C. G.
    Leufkens, H. G. M.
    van Staa, T. P.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S26 - S27
  • [2] Use of antipsychotics and risk of hip/femur fractures: A population based case-control study
    Pouwels, S.
    de Vries, F.
    Egberts, A. C. G.
    Letifliens, H. G. M.
    van Staa, T. P.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S168 - S168
  • [3] Use of antipsychotics and risk of hip/femur fractures: A population based case-control study
    Pouwels, Sander
    de Vries, Frank
    Egberts, Antoine C. G.
    Leufkens, Bert G. M.
    van Staa, Tjeerd P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S34 - S35
  • [4] Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
    S. Pouwels
    A. Lalmohamed
    P. Souverein
    C. Cooper
    B. J. Veldt
    H. G. Leufkens
    A. de Boer
    T. van Staa
    F. de Vries
    Osteoporosis International, 2011, 22 : 903 - 910
  • [5] Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
    Pouwels, S.
    Lalmohamed, A.
    Souverein, P.
    Cooper, C.
    Veldt, B. J.
    Leufkens, H. G.
    de Boer, A.
    van Staa, T.
    de Vries, F.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) : 903 - 910
  • [6] Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study
    Pouwels, S.
    van Staa, T. P.
    Egberts, A. C. G.
    Leufkens, H. G. M.
    Cooper, C.
    de Vries, F.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (09) : 1499 - 1506
  • [7] Selective serotonin reuptake inhibitors and the risk of stroke -: A population-based case-control study
    Bak, S
    Tsiropoulos, I
    Kjærsgaard, JO
    Andersen, M
    Mellerup, E
    Hallas, J
    Rodríguez, LAG
    Christensen, K
    Gaist, D
    STROKE, 2002, 33 (06) : 1465 - 1473
  • [8] Use of Dopaminergic Drugs and Risk of Hip or Femur Fracture: A Population-Based Case-Control Study
    Arbouw, Maurits
    Movig, Kris
    van Staa, Tjeerd
    Egberts, Toine
    Souverein, Patrick
    de Vries, Frank
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S201 - S202
  • [9] Selective serotonin reuptake inhibitors and risk of acute pancreatitis - A population-based case-control study
    Norgaard, Mette
    Jacobsen, Jacob
    Gasse, Christiane
    Pedersen, Lars
    Mortensen, Preben Bo
    Sorensen, Henrik Toft
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (03) : 259 - 262
  • [10] Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke: A population-based case-control study
    Kharofa, Jordan
    Sekar, Padmini
    Haverbusch, Mary
    Moowmaw, Charles
    Flaherty, Matthew
    Kissela, Brett
    Kleindorfer, Dawn
    Khatri, Pooja
    Broderick, Joseph
    Woo, Daniel
    STROKE, 2007, 38 (02) : 524 - 524